These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 25738841)
1. Identifying prognostic features by bottom-up approach and correlating to drug repositioning. Li W; Yu J; Lian B; Sun H; Li J; Zhang M; Li L; Li Y; Liu Q; Xie L PLoS One; 2015; 10(3):e0118672. PubMed ID: 25738841 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties. Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk. Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463 [TBL] [Abstract][Full Text] [Related]
4. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471 [TBL] [Abstract][Full Text] [Related]
5. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation. Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267 [TBL] [Abstract][Full Text] [Related]
6. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896 [TBL] [Abstract][Full Text] [Related]
7. A Computational Framework to Identify Transcriptional and Network Differences between Hepatocellular Carcinoma and Normal Liver Tissue and Their Applications in Repositioning Drugs. Hu A; Wei Z; Zheng Z; Luo B; Yi J; Zhou X; Zeng C Biomed Res Int; 2021; 2021():9921195. PubMed ID: 34604388 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma. Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575 [TBL] [Abstract][Full Text] [Related]
9. Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. Ivanovska I; Zhang C; Liu AM; Wong KF; Lee NP; Lewis P; Philippar U; Bansal D; Buser C; Scott M; Mao M; Poon RT; Fan ST; Cleary MA; Luk JM; Dai H PLoS One; 2011; 6(9):e24582. PubMed ID: 21949730 [TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283 [TBL] [Abstract][Full Text] [Related]
11. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma. Li B; Shao Q; Ji D; Li F; Guo X; Chen G Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637 [TBL] [Abstract][Full Text] [Related]
12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis. Hua S; Ji Z; Quan Y; Zhan M; Wang H; Li W; Li Y; He X; Lu L Aging (Albany NY); 2020 Mar; 12(6):5439-5468. PubMed ID: 32213663 [TBL] [Abstract][Full Text] [Related]
14. Random gene sets in predicting survival of patients with hepatocellular carcinoma. Itzel T; Spang R; Maass T; Munker S; Roessler S; Ebert MP; Schlitt HJ; Herr W; Evert M; Teufel A J Mol Med (Berl); 2019 Jun; 97(6):879-888. PubMed ID: 31001651 [TBL] [Abstract][Full Text] [Related]
15. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085 [TBL] [Abstract][Full Text] [Related]
16. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma. Zhai X; Xue Q; Liu Q; Guo Y; Chen Z Mol Med Rep; 2017 Sep; 16(3):3253-3261. PubMed ID: 28713927 [TBL] [Abstract][Full Text] [Related]
17. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation. Miltiadous O; Sia D; Hoshida Y; Fiel MI; Harrington AN; Thung SN; Tan PS; Dong H; Revill K; Chang CY; Roayaie S; Byrne TJ; Mazzaferro V; Rakela J; Florman S; Schwartz M; Llovet JM J Hepatol; 2015 Dec; 63(6):1368-77. PubMed ID: 26220754 [TBL] [Abstract][Full Text] [Related]
18. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B. Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223 [TBL] [Abstract][Full Text] [Related]
19. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma. Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Villanueva A; Portela A; Sayols S; Battiston C; Hoshida Y; Méndez-González J; Imbeaud S; Letouzé E; Hernandez-Gea V; Cornella H; Pinyol R; Solé M; Fuster J; Zucman-Rossi J; Mazzaferro V; Esteller M; Llovet JM; Hepatology; 2015 Jun; 61(6):1945-56. PubMed ID: 25645722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]